Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle

American Heart Journal

Volumn 157, Issue 1, 2009, Pages 37-45

  Hsu, Daphne T ^a   Mital, Seema ^a   Ravishankar, Chitra ^b   Margossian, Renee ^c   Li, Jennifer S ^d   Sleeper, Lynn A ^e   Williams, Richard V ^f   Levine, Jami C ^c   McCrindle, Brian W ^g   Atz, Andrew M ^h   Servedio, Darlene ^a   Mahony, Lynn ⁱ  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d DUKE UNIVERSITY   (United States)

^e NEW ENGLAND RESEARCH INSTITUTES   (United States)

^f PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁱ UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; PLACEBO;

ANGIONEUROTIC EDEMA; ARTICLE; BODY GROWTH; CHILD CARE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOSIS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG WITHDRAWAL; ENZYME INHIBITION; FEMALE; GENOTYPE; HEART FAILURE; HEART SINGLE VENTRICLE; HEART VENTRICLE FUNCTION; HEART VENTRICLE SIZE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; HYPOTENSION; INFANT; INFORMED CONSENT; KIDNEY DYSFUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEWBORN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCREENING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HUMANS; INFANT, NEWBORN; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 57149106114     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.08.030     Document Type: Article

References (30)

1. Cheung Y.F., Penny D.J., and Redington A.N. Serial Assessment of Left Ventricular Diastolic Function after Fontan Procedure. Heart 83 (2000) 420-424
2. Gentles T.A., Mayer J.E., Gauvreau K., et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 114 (1997) 376-391
3. Seliem M., Muster A.J., Paul M.H., et al. Relation between preoperative left ventricular muscle mass and outcome of the Fontan procedure in patients with tricuspid atresia. J Am Coll Cardiol 14 (1989) 750-755
4. Mori Y., Nakazawa M., Tomimatsu H., et al. Long term effect of angiotensin-converting enzyme inhibitor in volume overload heart during growth: a controlled pilot study. J Am Coll Cardiol 36 (2000) 270-275
5. Calabro R., Piscane C., Pacileo G., et al. Hemodynamic effects of a single oral dose of enalapril among children with asymptomatic chronic mitral regurgitation. Am J Cardiol 138 (1999) 955-961
6. Shaw N.J., Wilson N., and Dickinson D.F. Captopril in heart failure secondary to a left to right shunt. Arch Dis Child 63 (1988) 360-363
7. Scammell A.M., Arnold R., and Wilkinson J.L. Captopril in treatment of infant heart failure: a preliminary report. Int J Cardiol 16 (1987) 295-301
8. Frenneaux M., Stewart R.A.H., Newman C.M.H., et al. Enalapril for severe heart failure in infancy. Arch Dis Child 64 (1989) 219-223
9. Grenier M.A., Fioravanti J., Truesdell S.C., et al. Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a review. Prog Pediatr Cardiol 12 (2000) 91-111
10. Montigny M., Davignon A., Fouron J.C., et al. Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt. Am J Cardiol 63 (1989) 631-633
11. Seguchi M., Nakazawa M., and Momma K. Effect of enalapril on infants and children with congestive heart failure. Cardiol Young (1992) 14-19
12. Leitch C.A. Growth, nutrition and energy expenditure in pediatric heart failure. Prog Pediatr Cardiol 11 (2000) 195-202
13. Cameron J.W., Rosenthal A., and Olson A.D. Malnutrition in hospitalized children with congenital heart disease. Arch Pediatr Adolesc Med 149 (1995) 1098-1102
14. Cohen M.I., Bush D.M., Perry R.J., et al. Somatic growth failure after the Fontan operation. Cardiol Young 10 (2002) 447-457
15. Day R.W., Denton D.M., and Jackson W.D. Growth of children with a functionally single ventricle following palliation at moderately increased altitude. Cardiol Young 10 (2000) 193-200
16. Vogt K.N., Manlhiot C., Van Arsdell G., et al. Somatic growth in children with single ventricle physiology impact of physiologic state. J Am Coll Cardiol 50 (2007) 1876-1883
17. Mahony L., Sleeper L.A., Anderson P.A., et al. The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease. Pediatr Cardiol 27 (2006) 191-198
18. Ross R.D., Daniels S.R., Schwartz D.C., et al. Plasma norepinephrine levels in infants and children with congestive heart failure. Am J Cardiol 59 (1987) 911-914
19. Wu J., Chang H., Huang T., et al. Reduction in lymphocyte beta-adrenergic receptor density in infants and children with heart failure secondary to congenital heart disease. Am J Cardiol 77 (1996) 170-174
20. Shimizu H., Aono K., Masuta K., et al. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta 285 (1999) 169-172
21. Bayley N. Bayley Scales of Infant Development. 2nd ed. (1993), Psychol. Corp., San Antonio (TX)
22. Fenson L., Dale P., Reznick S., et al. MacArthur Communicative Development Inventories: User's Guide and Technical Manual (1993), Singular Publishing Group, San Diego (CA)
23. Bernstein D., Starnes V.A., and Baum D. Pediatric heart transplantation. Adv Pediatr 37 (1990) 413-439
24. Tabbutt S., Nord A.S., Jarvik G.P., et al. Neurodevelopmental outcomes after staged palliation for hypoplastic left heart syndrome. Pediatrics 121 (2008) 476-483
25. Missmer S., Spiegelman D., Gorbach S., et al. Predictors of change in the functional status of children with human immunodeficiency virus infection. Pediatrics 106 (2000). http://www.pediatrics.org/cgi/content/full/106/2/e24 Last accessed November 21, 2008.
26. Sleeper L.A., Anderson P., Hsu D.T., et al. Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J 152 (2006) 427-433
27. Ortlepp J.R., Vosberg H.P., Reith S., et al. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 87 (2002) 270-275
28. Kurland L., Melhus H., Karlsson J., et al. Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens 20 (2002) 657-663
29. Matsumoto T., Wada A., Ohnishi M., et al. Chymase gene Expresses in only the Severe Stages of Heart Failure, while ACE Gene Expresses throughout the Cardiac Remodeling Process. Circulation (2000) 2191 [Abstract]
30. Lan K., and DeMets D. Discrete sequential boundaries for clinical trials. Biometrika 70 (1983) 659-663